J. Ezenfis

696 total citations
10 papers, 217 citations indexed

About

J. Ezenfis is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, J. Ezenfis has authored 10 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in J. Ezenfis's work include Pancreatic and Hepatic Oncology Research (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and Advanced Breast Cancer Therapies (1 paper). J. Ezenfis is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and Advanced Breast Cancer Therapies (1 paper). J. Ezenfis collaborates with scholars based in France and Lebanon. J. Ezenfis's co-authors include Julien Taı̈eb, Thierry Lecomte, C. Locher, Jean‐Marc Sabaté, A. Attar, David Laharie, Thomas Aparicio, David Malka, Franck Bonnetain and Valérie Boige and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

J. Ezenfis

8 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Ezenfis France 5 106 103 96 72 47 10 217
Nicole Villafañe-Ferriol United States 8 208 2.0× 73 0.7× 192 2.0× 95 1.3× 23 0.5× 10 301
Silvia Stragliotto Italy 9 58 0.5× 163 1.6× 112 1.2× 43 0.6× 48 1.0× 14 287
Ryota Matsui Japan 12 140 1.3× 187 1.8× 57 0.6× 103 1.4× 49 1.0× 46 289
Damien Botsen France 7 30 0.3× 89 0.9× 74 0.8× 30 0.4× 50 1.1× 29 171
O. Hynes United Kingdom 3 174 1.6× 193 1.9× 52 0.5× 67 0.9× 80 1.7× 5 258
Toshikatsu Tsuji Japan 11 124 1.2× 90 0.9× 53 0.6× 174 2.4× 22 0.5× 51 294
Oonagh Griffin Ireland 7 117 1.1× 116 1.1× 121 1.3× 13 0.2× 46 1.0× 13 239
Tim Wilson United Kingdom 6 106 1.0× 38 0.4× 86 0.9× 36 0.5× 28 0.6× 10 176
Delky Meza-Valderrama Spain 7 36 0.3× 211 2.0× 29 0.3× 31 0.4× 84 1.8× 14 257
Jeroen W. G. Derksen Netherlands 8 23 0.2× 66 0.6× 99 1.0× 18 0.3× 24 0.5× 21 182

Countries citing papers authored by J. Ezenfis

Since Specialization
Citations

This map shows the geographic impact of J. Ezenfis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ezenfis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ezenfis more than expected).

Fields of papers citing papers by J. Ezenfis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ezenfis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ezenfis. The network helps show where J. Ezenfis may publish in the future.

Co-authorship network of co-authors of J. Ezenfis

This figure shows the co-authorship network connecting the top 25 collaborators of J. Ezenfis. A scholar is included among the top collaborators of J. Ezenfis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Ezenfis. J. Ezenfis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ezenfis, J., et al.. (2021). Masitinib plus gemcitabine as first-line treatment of pancreatic cancer with pain: Results from phase 3 study AB12005.. Journal of Clinical Oncology. 39(15_suppl). 4018–4018. 4 indexed citations
2.
Lejeune, Marie, et al.. (2021). Diabète induit par l’alpelisib : à propos d’un cas. Médecine des Maladies Métaboliques. 15(4). 398–401.
3.
4.
Lepage, Côme, Laurent Cany, E. Maillard, et al.. (2016). Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer - PRODIGE 13 a FFCD and Unicancer phase III trial: baseline characteristics. Annals of Oncology. 27. vi159–vi159. 3 indexed citations
5.
Laplanche, A., Moncef Feki, Nathalie Bouvet, et al.. (2015). 1555 BEAUTY, a large randomised controlled trial of beauty care for early stage breast cancer patients receiving adjuvant chemotherapy: Impact on body image-related quality of life. European Journal of Cancer. 51. S222–S223. 1 indexed citations
6.
Attar, A., David Malka, Jean‐Marc Sabaté, et al.. (2012). Malnutrition Is High and Underestimated During Chemotherapy in Gastrointestinal Cancer: An AGEO Prospective Cross-Sectional Multicenter Study. Nutrition and Cancer. 64(4). 535–542. 107 indexed citations
7.
Taı̈eb, Julien, Emmanuel Mitry, Valérie Boige, et al.. (2002). Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma. Annals of Oncology. 13(8). 1192–1196. 78 indexed citations
8.
Reimund, J.M., et al.. (2002). The Phosphodiesterase Inhibitor, Pentoxifylline, Alters Rat Intestinal Epithelial Cell Proliferation via Changes in the Expression of Transforming Growth Factors. Scandinavian Journal of Gastroenterology. 37(2). 206–214. 7 indexed citations
9.
Taı̈eb, Julien, Thierry Lecomte, J. Ezenfis, et al.. (2002). [5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer].. PubMed. 26(6-7). 605–9. 10 indexed citations
10.
Reimund, Jean‐Marie, et al.. (1999). Nitric oxide end products in patients hospitalized for diarrhoea. European Journal of Gastroenterology & Hepatology. 11(9). 1013–1018. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Villafañe-Ferriol Breakdown of academic impact, for papers by Silvia Stragliotto Breakdown of academic impact, for papers by Ryota Matsui Breakdown of academic impact, for papers by Damien Botsen Breakdown of academic impact, for papers by O. Hynes Breakdown of academic impact, for papers by Toshikatsu Tsuji Breakdown of academic impact, for papers by Oonagh Griffin Breakdown of academic impact, for papers by Tim Wilson Breakdown of academic impact, for papers by Delky Meza-Valderrama Breakdown of academic impact, for papers by Jeroen W. G. Derksen
Rankless by CCL
2026